| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/17/2005 | DE10106362B4 Vorrichtung und Verfahren zum Sammeln von wässrigen Flüssigkeitsproben Device and method for collecting aqueous liquid samples |
| 03/17/2005 | CA2576406A1 Cell-based assays for determining drug action |
| 03/17/2005 | CA2540198A1 Tick engorgement factor proteins |
| 03/17/2005 | CA2538189A1 Novel markers for alternatively activated macrophages |
| 03/17/2005 | CA2537984A1 Detection of cholesterol ozonation products |
| 03/17/2005 | CA2537968A1 Methods and kits for detection of prion diseases |
| 03/17/2005 | CA2537955A1 Diagnostic marker for ovarian cancer |
| 03/17/2005 | CA2537844A1 Treatment of neurodegenerative diseases |
| 03/17/2005 | CA2537798A1 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof |
| 03/17/2005 | CA2537736A1 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof |
| 03/17/2005 | CA2537588A1 Device and process for the quantitative evaluation of the polypeptides contained in a body fluid sample, and marker for the detection of pathological states |
| 03/17/2005 | CA2537581A1 Sample processing system |
| 03/17/2005 | CA2537306A1 Methods employing combinatorial artificial receptors |
| 03/17/2005 | CA2537264A1 Building blocks for artificial receptors |
| 03/17/2005 | CA2537254A1 Methods for identifying, diagnosing, and predicting survival of lymphomas |
| 03/17/2005 | CA2525972A1 Methods for identifying inhibitors |
| 03/16/2005 | EP1515144A1 Method of assay with sulfonic acid compound and nitro compound |
| 03/16/2005 | EP1515143A1 Method of assay by oxidation-reduction reaction with formazan |
| 03/16/2005 | EP1515142A1 Mass spectrometry methods for direct phenotyping of factor XIIIA polymorphisms |
| 03/16/2005 | EP1515141A1 Culture Flask |
| 03/16/2005 | EP1515140A2 Fluidics circuit of hermatology analyzer with heated reaction chamber |
| 03/16/2005 | EP1515139A2 Method of determining the fluid condition of diesel engine lubricant during real time operation |
| 03/16/2005 | EP1514945A1 CD38 as a molecular marker on macrophages for COPD, and as a target molecule for treatment of COPD |
| 03/16/2005 | EP1514944A1 High-throughput-Assay with high sensitivity for measuring of the activity of beta-adrenergic receptor kinase and for determining the impact of test substances on such activity |
| 03/16/2005 | EP1514943A1 Non-invasive analysis and detection of micro-organisms in dairy products contained in laminated paper or carton containers, using elastic waves by means of dry coupling |
| 03/16/2005 | EP1514942A1 Method of searching substane having antidiabetic activity |
| 03/16/2005 | EP1514932A2 Glucagon receptors |
| 03/16/2005 | EP1514931A1 Immunosuppressant target proteins |
| 03/16/2005 | EP1514930A1 Novel screening method |
| 03/16/2005 | EP1514926A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| 03/16/2005 | EP1514925A1 Method of screening compound affecting amyloid beta production |
| 03/16/2005 | EP1514922A1 Development of an anionic sensor for living cells: application to the human glycine receptor |
| 03/16/2005 | EP1514920A1 Methods and device for adhesive control of internal cell organisation |
| 03/16/2005 | EP1514876A2 Antibody against prostate stem cell antigen (PSCA) |
| 03/16/2005 | EP1514597A1 Isolation material for hormone disrupting substance, method of concentrating and method of clean-up |
| 03/16/2005 | EP1514596A2 Device substrate, method of manufacturing the same, and microchip |
| 03/16/2005 | EP1514578A1 Non-destructive method of predicting performance of ceramic components |
| 03/16/2005 | EP1514213A2 Computer systems and methods for subdividing a complex disease into component diseases |
| 03/16/2005 | EP1514151A1 A method of and apparatus for screening to identify drug candidates |
| 03/16/2005 | EP1514135A1 Differential indication of labeled molecules |
| 03/16/2005 | EP1514120A2 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins |
| 03/16/2005 | EP1514119A2 DIAGNOSTIC POLYMORPHISM OF 11s-HYDROXYSTEROID DEHYDROGENASE USEFUL FOR IDENTIFYING RISK OF DEVELOPING ALZHEIMER S DISEA SE |
| 03/16/2005 | EP1514118A2 Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases |
| 03/16/2005 | EP1514117A1 Methods for avoiding renal injury |
| 03/16/2005 | EP1514116A1 Oxaliplatin anti-resistance agent |
| 03/16/2005 | EP1514115A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 03/16/2005 | EP1514114A2 Method to screen ligands using eukaryotic cell display |
| 03/16/2005 | EP1514113A1 Method for diagnosing sepsis by determining anti-asialoganglioside antibodies |
| 03/16/2005 | EP1514112A2 Method for isolating an allosteric effector of a receptor |
| 03/16/2005 | EP1514111A1 Coated metal surface on solid support for displacement reactions |
| 03/16/2005 | EP1514110A2 An apparatus and method for two-dimensional electron gas actuation and transduction for gaas nems |
| 03/16/2005 | EP1514109A1 Coated metal surface on solid support useful in analyte detection by displacement |
| 03/16/2005 | EP1514107A2 Methods for quantitative proteome analysis of glycoproteins |
| 03/16/2005 | EP1514105A2 Methods of modulating tubulin deacetylase activity |
| 03/16/2005 | EP1514104A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 03/16/2005 | EP1514103A1 Measuring nitric oxide in blood gases and treatments based thereon |
| 03/16/2005 | EP1514097A1 Microfabricated sensor arrays |
| 03/16/2005 | EP1514096A2 Hybrid microcantilever sensors |
| 03/16/2005 | EP1514090A2 Total organic carbon (toc) analyzer |
| 03/16/2005 | EP1513959A2 Antiviral inhibitions of capsid proteins |
| 03/16/2005 | EP1513955A2 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
| 03/16/2005 | EP1513954A2 Device and method of use for detection and characterization of pathogens and biological materials |
| 03/16/2005 | EP1513953A1 Method for high-throughput integrated chemical and biochemical reactions |
| 03/16/2005 | EP1513950A1 Application of cantilevers in nucleic acid sequencing |
| 03/16/2005 | EP1513948A1 Integrated micro array system and methods therefor |
| 03/16/2005 | EP1513932A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 03/16/2005 | EP1513921A1 A method of cell therapy using fused cell hybrids |
| 03/16/2005 | EP1513879A2 Synthetic antibody phage libraries |
| 03/16/2005 | EP1513877A1 Marker for stem cells and its use |
| 03/16/2005 | EP1513876A2 Human 5-ht7 receptor promoter sequence |
| 03/16/2005 | EP1513875A2 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 03/16/2005 | EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 03/16/2005 | EP1513869A2 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 03/16/2005 | EP1513866A2 Assay conjugate and uses thereof |
| 03/16/2005 | EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/16/2005 | EP1513860A2 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 03/16/2005 | EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 03/16/2005 | EP1513848A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 03/16/2005 | EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 03/16/2005 | EP1513558A2 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1alpha |
| 03/16/2005 | EP1513553A1 Methods and materials for treating inflammatory conditions |
| 03/16/2005 | EP1470421A4 Rapid prion-detection assay |
| 03/16/2005 | EP1438586A4 Fret protease assays for clostridial toxins |
| 03/16/2005 | EP1432731A4 Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma |
| 03/16/2005 | EP1366360A4 Methods for large scale protein matching |
| 03/16/2005 | EP1348123B1 Analysis method for detecting three-dimensional trace element distribution patterns and corresponding device for carrying out this method |
| 03/16/2005 | EP1346229B1 Inverse labeling method for the rapid identification of marker/target proteins |
| 03/16/2005 | EP1282688B1 Ammonia-oxidizing bacteria |
| 03/16/2005 | EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 03/16/2005 | EP1266037A4 High throughput screening by measurement of intracellular calcium levels |
| 03/16/2005 | EP1242626A4 Detection of nucleic acids |
| 03/16/2005 | EP1239775B1 Device for enhancing transdermal flux of sampled agents |
| 03/16/2005 | EP1228374B1 Immunoassay of c-peptide containing impurities in recombinant human insulin |
| 03/16/2005 | EP1181392A4 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 03/16/2005 | EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 03/16/2005 | EP1112254A4 Cyanine dyes and synthesis methods thereof |
| 03/16/2005 | EP1027456B1 Expression profiles in adult and fetal organs |
| 03/16/2005 | EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 03/16/2005 | EP0874625B1 Indane derivatives for antipsychotic compositions |
| 03/16/2005 | EP0865606B1 Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system with on-board informatics |